Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × Cyclophosphamide × Clear all

NCT06119685 2025-06-03

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms

NCT02999854 2022-05-24

HATCY

Phase 3 Terminated

63 enrolled 14 charts

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03344705 2017-11-17

Safety and Efficacy Evaluation of IM19 Cells

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms